OPK Opko Health, Inc. - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 28, 2026
$1,56
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$0,9852-Wochen-Tief
$1,7552-Wochen-Hoch
P/E (TTM)
-17.3
EPS (TTM)
$-0.09
Umsatz (TTM)
$588M
Ihre Abzeichen
52W-Spanne
$1–$2
Analystenbewertung
BUY
Kursziel
$4
P/E
-17.3
ROE
-5.9%
Nettogewinnmarge
-12.4%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
OPK Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.56
P/E (TTM)
-17.3
EPS (TTM)
$-0.09
Umsatz (TTM)
$588M
ROE (TTM)
-5.9%
Verschuldungsgrad (MRQ)
0.0
52W-Spanne
$1–$2
OPK Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$607M2016-12-31 → 2025-12-31
EPS$-0.302016-12-31 → 2025-12-31
Freier Cashflow$-191M2016-12-31 → 2025-12-31
Nettogewinnmarge-12.4%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | OPK | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -17.35-Jahres-Durchschnitt ≈-25.5 | ≈-25.5 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 4.75-Jahres-Durchschnitt ≈11.6 | ≈11.6 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | OPK | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 40.8% | · | 30.6% | Spitzenklasse | |
| Betriebsgewinnmarge (TTM) | -8.2%5-Jahres-Durchschnitt ≈-20.0% | ≈-20.0% | 2.4% | Schwach | |
| EBITDA-Marge (TTM) | 7.1%5-Jahres-Durchschnitt ≈-7.3% | ≈-7.3% | 4.0% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | -13.6%5-Jahres-Durchschnitt ≈-33.4% | ≈-33.4% | 2.6% | Schwach | |
| Nettogewinnmarge (TTM) | -12.4%5-Jahres-Durchschnitt ≈-30.6% | ≈-30.6% | 1.1% | Schwach | |
| ROA (TTM) | -3.8%5-Jahres-Durchschnitt ≈-11.4% | ≈-11.4% | -4.3% | Schwach | |
| ROE (TTM) | -5.9%5-Jahres-Durchschnitt ≈-17.2% | ≈-17.2% | -5.4% | Schwach | |
| ROIC | -6.8%5-Jahres-Durchschnitt ≈-10.1% | ≈-10.1% | -6.8% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | OPK | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.0 | · | 0.0 | Geringe Verschuldung | |
| Liquiditätsgrad (MRQ) | 3.35-Jahres-Durchschnitt ≈2.5 | ≈2.5 | 1.3 | Starke Liquidität | |
| Quick Ratio | 3.15-Jahres-Durchschnitt ≈1.8 | ≈1.8 | 1.0 | Starke Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.0 | · | 0.1 | Geringe Verschuldung |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | OPK | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -14.9%5-Jahres-Durchschnitt ≈-13.2% | ≈-13.2% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -15.4%5-Jahres-Durchschnitt ≈-19.1% | ≈-19.1% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -15.8% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | OPK | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.35-Jahres-Durchschnitt ≈0.4 | ≈0.4 | 1.2 | Schwach | |
| Inventory Turnover (Lagerumschlag) | 6.5 | · | 9.8 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 5.85-Jahres-Durchschnitt ≈6.0 | ≈6.0 | 7.3 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$266.8K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
31.1%
Nächster Bericht
Okt 27, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 29, 2026 | $-0.01 | $-0.08 | 87.6% |
| 31. März 2026 | Mai 12, 2026 | $-0.07 | $-0.07 | 0.99% |
| 31. Dezember 2025 | $-0.04 | $-0.07 | 42.3% | |
| 30. September 2025 | $0.03 | $-0.05 | 165.9% | |
| 30. Juni 2025 | $-0.19 | $-0.11 | -65.9% | |
| 31. März 2025 | $-0.10 | $-0.07 | -44.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $607M | $713M | $863M | $1.00B | $1.77B | $1.44B | $902M | $990M | $966M | $1.12B | $492M | $91M | |
| Cost of Revenue | $401M | $495M | $545M | $716M | · | · | · | · | $61M | $47M | $42M | $9M | |
| Gross Profit | $206M | $219M | $318M | $288M | · | · | · | · | · | · | · | · | |
| R&D Expense | $124M | $105M | $90M | $74M | $77M | $75M | $118M | $126M | $126M | $114M | $99M | $84M | |
| SG&A Expense | $223M | $304M | $301M | $373M | $469M | $356M | $343M | $358M | $415M | $407M | $197M | $58M | |
| Operating Expenses | · | · | $1.02B | $1.23B | $1.76B | $1.38B | $1.18B | $1.16B | $1.24B | $1.21B | $590M | $237M | |
| Operating Income | $-117M | $-152M | $-157M | $-226M | $19M | $58M | $-274M | $-171M | $-276M | $-97M | $-98M | $-146M | |
| Interest Expense | $0 | · | $14M | $12M | $19M | · | · | · | · | · | · | · | |
| Interest Income | $15M | $8M | $4M | $2M | $28.0K | · | · | · | · | · | · | · | |
| Other Non-op | $-30M | $207M | $-17M | $-156M | $-15M | $13M | $-11M | $2M | $10M | $4M | $8M | $-3M | |
| Pretax Income | $-241M | $-10M | $-184M | $-392M | $-14M | $49M | $-305M | $-177M | $-272M | $-97M | $-138M | $-171M | |
| Income Tax | $-16M | $43M | $4M | $-63M | $15M | $18M | $7M | $-39M | $19M | $-56M | $-114M | $24.0K | |
| Net Income | $-226M | $-53M | $-189M | $-328M | $-30M | $31M | $-315M | $-153M | $-305M | $-48M | $-30M | $-172M | |
| EPS (Basic) | $-0.30 | $-0.08 | $-0.25 | $-0.46 | $-0.05 | $0.05 | $-0.53 | $-0.27 | $-0.55 | $-0.09 | · | · | |
| EPS (Diluted) | $-0.30 | $-0.08 | $-0.25 | $-0.46 | $-0.05 | $0.05 | $-0.53 | $-0.27 | $-0.55 | $-0.10 | · | · | |
| Shares (Basic) | 751,132,891 | 694,019,535 | 751,765,915 | 719,060,942 | 648,077,716 | 640,655,290 | 595,454,394 | 563,143,663 | 559,160,565 | 550,846,553 | · | · | |
| Shares (Diluted) | 751,132,891 | 694,019,535 | 751,765,915 | 719,060,942 | 648,077,716 | 640,655,290 | 595,454,394 | 563,143,663 | 559,160,565 | 555,605,448 | · | · | |
| EBITDA | $-26M | · | $-52M | $-118M | · | $143M | $-180M | $-74M | $-178M | $23M | · | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $364M | $427M | $96M | $153M | $135M | $72M | $85M | $96M | $91M | $169M | $194M | $97M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Receivables | $90M | $118M | $123M | $127M | $260M | $286M | $135M | $144M | $166M | $220M | $194M | $20M | |
| Inventory | $66M | $57M | $66M | $74M | $87M | $132M | $53M | $42M | $49M | $47M | $40M | $17M | |
| Prepaid Expense | $57M | $55M | $25M | $40M | $27M | $32M | $51M | $35M | $43M | $47M | $27M | $9M | |
| Other Current Assets | $8M | $11M | $8M | $6M | $6M | $5M | $16M | $4M | $9M | $8M | $903.0K | $4M | |
| Current Assets | $582M | $662M | $309M | $395M | $823M | $523M | $324M | $318M | $349M | $484M | $454M | $143M | |
| PP&E (Net) | $74M | $70M | $75M | $83M | · | $141M | $127M | $145M | $147M | $123M | $132M | $16M | |
| Accum. Depreciation | $126M | $139M | $157M | $142M | · | · | · | $112M | $86M | $57M | $27M | $11M | |
| Goodwill | $484M | $529M | $598M | $596M | $521M | $681M | $672M | $700M | $717M | $705M | $743M | $224M | |
| Intangibles | $516M | $617M | $740M | $824M | $322M | $475M | $529M | $614M | $684M | $764M | $638M | $63M | |
| Other Non-current Assets | $19M | $19M | $9M | $9M | $10M | $10M | $7M | $7M | $6M | $6M | $5M | $6M | |
| Total Assets | $1.93B | $2.20B | $2.01B | $2.17B | $2.40B | $2.47B | $2.31B | $2.45B | $2.59B | $2.77B | $2.80B | $1.27B | |
| Accounts Payable | $41M | $47M | $70M | $67M | $82M | $101M | $63M | $47M | $74M | $53M | $73M | $9M | |
| Accrued Liabilities | $84M | $118M | $90M | $98M | $193M | $241M | $165M | $204M | $226M | $198M | $168M | $61M | |
| Current Liabilities | $147M | $193M | $200M | $213M | $330M | $375M | $249M | $288M | $312M | $263M | $252M | $83M | |
| Capital Leases | $37M | $49M | $54M | $28M | $33M | $30M | $28M | $6M | $8M | $7M | $9M | $0 | |
| Deferred Tax | $126M | $141M | $127M | $126M | $148M | $137M | $119M | $115M | $149M | $165M | $226M | $167M | |
| Other Non-current Liabilities | $23M | $33M | $27M | $27M | $15M | $37M | $88M | $199M | $256M | $202M | $292M | $50M | |
| Total Liabilities | $664M | $835M | $622M | $606M | $715M | $802M | $695M | $660M | $746M | $675M | $819M | $432M | |
| Long-term Debt | $344M | $437M | $50.6K | $256M | $205M | $251M | $270M | $11M | $13M | $13M | $14M | $16M | |
| Total Debt | $346M | · | $10M | · | · | · | $4M | $11M | $13M | $13M | · | · | |
| Common Stock | $8M | $7M | $8M | $8M | $7M | $7M | $7M | $6M | $6M | $6M | $5M | $4M | |
| Paid-in Capital | $3.57B | $3.48B | $3.43B | $3.42B | $3.22B | $3.15B | $3.14B | $3.00B | $2.89B | $2.85B | $2.71B | $1.53B | |
| Retained Earnings | $-2.29B | $-2.07B | $-2.01B | $-1.82B | $-1.51B | $-1.48B | $-1.51B | $-1.20B | $-1.05B | $-730M | $-705M | $-675M | |
| Treasury Stock | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $4M | |
| AOCI | $-21M | $-56M | $-38M | $-43M | $-30M | $-4M | $-22M | $-20M | $-528.0K | $-27M | $-23M | $-12M | |
| Stockholders' Equity | $1.27B | $1.37B | $1.39B | $1.56B | $1.69B | $1.67B | $1.61B | $1.79B | $1.84B | $2.05B | $1.96B | $836M | |
| Liabilities + Equity | $1.93B | $2.20B | $2.01B | $2.17B | $2.40B | $2.47B | $2.31B | $2.45B | $2.59B | $2.77B | $2.80B | $1.27B | |
| Shares Outstanding | · | 701,350,447 | 781,936,885 | 781,306,164 | 690,082,283 | 670,585,576 | 670,378,701 | · | · | · | · | · |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $92M | $98M | $105M | $109M | $79M | $85M | $94M | $97M | $102M | $97M | $42M | $15M | |
| Stock-based Comp | $11M | $11M | $11M | $19M | $14M | $9M | $13M | $22M | $28M | $43M | $26M | $15M | |
| Deferred Tax | $-15M | $15M | $146.0K | $-74M | $10M | $16M | $4M | $-35M | $16M | $-61M | $-124M | $-1M | |
| Amort. of Intangibles | $78M | $83M | $86M | $88M | $50M | $56M | $65M | $68M | $71M | $64M | $28M | $11M | |
| Other Non-cash | $-40M | · | $44M | $180M | · | $-101M | $31M | $-40M | $70M | $-21M | · | · | |
| Operating Cash Flow | $-179M | $-183M | $-28M | $-95M | $38M | $39M | $-173M | $-109M | $-92M | $32M | $164M | $-90M | |
| CapEx | $12M | $25M | $16M | $25M | $32M | $34M | $13M | $28M | $47M | $19M | $11M | $5M | |
| Investing Cash Flow | $230M | $352M | $-18M | $91M | $36M | $-18M | $-13M | $-26M | $-47M | $-21M | $-99M | $-6M | |
| Stock Issued | · | · | · | · | $0 | $0 | $76M | $92M | $0 | $0 | · | · | |
| Stock Repurchased | $47M | $90M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-47M | · | · | · | · | $0 | $76M | $92M | · | · | · | · | |
| Financing Cash Flow | $-118M | $184M | $-11M | $23M | $-10M | $-35M | $175M | $141M | $61M | $-35M | $33M | $7M | |
| Net Change in Cash | $-63M | $350M | $-57M | $18M | $62M | $-13M | $-11M | $5M | $-77M | $-25M | $97M | $-89M | |
| Taxes Paid | $24M | $10M | $4M | $8M | $6M | $-903.0K | $3M | $-1M | $5M | $-27M | $5M | $954.0K | |
| Free Cash Flow | $-191M | · | $-44M | $-120M | · | $6M | $-185M | $-137M | $-139M | $13M | · | · | |
| Levered FCF | $-191M | · | $-58M | · | · | · | · | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 33.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -19.4% | · | -18.2% | -22.5% | · | 4.0% | -30.4% | -17.3% | -26.2% | -6.0% | · | · | |
| Net Margin | -37.2% | · | -21.9% | -32.7% | · | 2.1% | -34.9% | -15.4% | -28.9% | -2.1% | · | · | |
| Pretax Margin | -39.8% | · | -21.3% | -39.0% | · | 3.4% | -33.8% | -17.9% | -25.8% | -6.0% | · | · | |
| EBITDA Margin | -4.2% | · | -6.0% | -11.7% | · | 10.0% | -20.0% | -7.5% | -16.7% | 1.9% | · | · | |
| ROA | -10.9% | · | -9.0% | -14.4% | · | 1.3% | -13.2% | -6.1% | -11.5% | -0.90% | · | · | |
| ROE | -17.6% | · | -13.3% | -20.6% | · | 1.9% | -19.3% | -8.6% | -15.7% | -1.2% | · | · | |
| ROIC | -6.8% | · | -11.5% | -12.1% | · | 2.2% | -17.3% | -7.4% | -15.8% | -0.83% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.0 | · | 1.5 | 1.8 | · | 1.4 | 1.3 | 1.1 | 1.1 | 1.8 | · | · | |
| Quick Ratio | 3.1 | · | 1.1 | 1.3 | · | 1.0 | 0.9 | 0.8 | 0.9 | 1.5 | · | · | |
| Debt / Equity | 0.3 | · | 0.0 | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | · | |
| LT Debt / Equity | 0.0 | · | 0.0 | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | -11.6 | · | · | · | · | · | · | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | · | 0.4 | 0.4 | · | 0.6 | 0.4 | 0.4 | 0.4 | 0.4 | · | · | |
| Inventory Turnover | 6.5 | · | · | · | · | · | · | · | 1.3 | 13.0 | · | · | |
| Receivables Turnover | 5.8 | · | 6.9 | 5.2 | · | 6.8 | 6.5 | 6.4 | 5.5 | 5.9 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | $1.78 | $2.00 | · | · | · | · | · | · | · | · | |
| Revenue / Share | $0.81 | · | · | $1.40 | · | · | · | $1.76 | · | · | · | · | |
| Cash Flow / Share | $-0.24 | · | · | $-0.13 | · | · | · | $-0.19 | · | · | · | · | |
| Cash / Share | · | · | $0.12 | $0.20 | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $-0.30 | $-0.08 | $-0.25 | $-0.46 | $-0.05 | $0.05 | $-0.53 | $-0.27 | $-0.55 | $-0.10 | $-0.17 | $-0.42 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -14.9% | -17.4% | -14.0% | -43.4% | 23.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -15.4% | -26.2% | -15.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -15.8% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $607M | $713M | $863M | $1.00B | $1.77B | $1.44B | $902M | $990M | $966M | $1.12B | $492M | $91M | |
| Net Income TTM | $-226M | $-53M | $-189M | $-328M | $-30M | $31M | $-315M | $-153M | $-305M | $-48M | $-30M | $-172M | |
| Market Cap | · | · | $1.18B | $977M | · | · | · | · | · | · | · | · | |
| Enterprise Value | · | · | $1.09B | · | · | · | · | · | · | · | · | · | |
| P/E | -4.2 | -18.4 | -6.0 | -2.7 | -96.2 | 79.0 | -2.8 | -11.1 | -8.9 | -93.0 | -59.1 | -23.8 | |
| P/S | · | · | 1.4 | 1.0 | · | · | · | · | · | · | · | · | |
| P/B | · | · | 0.8 | 0.6 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | · | 4.7 | 23.3 | 6.9 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | · | -41.9 | -10.3 | · | · | · | · | · | · | · | · | |
| P / FCF | · | · | -26.5 | -8.2 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | · | · | -21.2 | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | · | -24.6 | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | 1.3 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -23.8% | -5.4% | -16.6% | -36.8% | -1.0% | 1.3% | -36.0% | -9.0% | -11.2% | -1.1% | -1.7% | -4.2% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $164M | $124M | $148M | $152M | $157M | $150M | $184M | $174M | $182M | $174M | $182M | $179M | $265M | $238M | $185M | $180M | |
| Cost of Revenue | $84M | $78M | $84M | $102M | $107M | $107M | $99M | $134M | $131M | $132M | · | · | · | · | · | · | |
| Gross Profit | $80M | $46M | $64M | $50M | $49M | $43M | $85M | $40M | $52M | $42M | · | · | · | · | · | · | |
| R&D Expense | $33M | $29M | $33M | $30M | $30M | $31M | $30M | $29M | $24M | $22M | $19M | $19M | $18M | $33M | $20M | $19M | |
| SG&A Expense | $53M | $49M | $51M | $54M | $60M | $59M | $67M | $98M | $69M | $70M | $73M | $72M | $80M | $76M | $74M | $80M | |
| Operating Expenses | $171M | $175M | $187M | $104M | $217M | $217M | $217M | $159M | $244M | $245M | $251M | $243M | $258M | $268M | $241M | $268M | |
| Operating Income | $-7M | $-51M | $-38M | $48M | $-60M | $-67M | $-33M | $-67M | $-62M | $-71M | $-69M | $-64M | $7M | $-31M | $-55M | $-88M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $8M | · | $3M | $3M | $3M | · | $3M | |
| Interest Income | $3M | $3M | $4M | $3M | $3M | $5M | $4M | $3M | $391.0K | $813.0K | $906.0K | $970.0K | $1M | $1M | $1M | $667.0K | |
| Other Non-op | $2M | $-2M | $-960.0K | $2M | $-36M | $5M | $78M | $49M | $59M | $21M | $-949.0K | $-12M | $-21M | $17M | $-45M | $-37M | |
| Pretax Income | $-13M | $-61M | $-47M | $41M | $-163M | $-73M | $35M | $48M | $-11M | $-83M | $-72M | $-78M | $-16M | $-17M | $-102M | $-126M | |
| Income Tax | $-5M | $-6M | $-16M | $20M | $-14M | $-6M | $21M | $24M | $-280.0K | $-1M | $-6M | $6M | $3M | $1M | $-17M | $-40M | |
| Net Income | $-8M | $-55M | $-31M | $22M | $-148M | $-68M | $14M | $25M | $-10M | $-82M | $-66M | $-84M | $-20M | $-18M | $-85M | $-86M | |
| EPS (Basic) | $-0.01 | $-0.07 | $-0.04 | $0.03 | $-0.19 | $-0.10 | $0.02 | $0.04 | $-0.01 | $-0.12 | $-0.09 | $-0.11 | $-0.03 | $-0.02 | $-0.13 | $-0.11 | |
| EPS (Diluted) | $-0.01 | $-0.07 | $-0.04 | $0.03 | $-0.19 | $-0.10 | $0.01 | $0.03 | $-0.01 | $-0.12 | $-0.09 | $-0.11 | · | $-0.02 | $-0.11 | $-0.11 | |
| Shares (Basic) | 755,267,276 | 758,876,415 | · | 777,154,808 | 788,006,992 | 671,577,429 | · | 694,622,466 | 697,211,592 | 706,882,189 | · | 751,525,007 | 751,727,383 | 751,506,257 | · | 750,396,263 | |
| Shares (Diluted) | 755,267,276 | 758,876,415 | · | 779,919,259 | 788,006,992 | 671,577,429 | · | 998,363,636 | 697,211,592 | · | · | 751,525,007 | · | 751,506,257 | · | 750,396,263 | |
| EBITDA | $15M | $-29M | · | $71M | $-37M | $-44M | · | $38M | $-38M | $-46M | · | $-38M | $33M | $-4M | · | $-60M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $301M | $332M | $364M | $412M | $267M | $429M | $427M | $400M | $41M | $76M | · | $139M | $108M | $111M | · | $181M | |
| Receivables | $82M | $80M | $90M | $95M | $99M | $96M | $118M | $107M | $105M | $111M | · | $117M | $211M | $121M | · | $123M | |
| Inventory | $62M | $64M | $66M | $65M | $66M | $64M | $57M | $59M | $60M | $59M | · | $69M | $74M | $75M | · | $71M | |
| Prepaid Expense | $56M | $49M | $57M | $52M | $59M | $54M | $55M | $57M | $32M | $25M | · | $32M | $41M | $99M | · | $39M | |
| Other Current Assets | $10M | $10M | $8M | $8M | $8M | $11M | $11M | $9M | $7M | $7M | · | $7M | $7M | $6M | · | $6M | |
| Current Assets | $500M | $535M | $582M | $627M | $583M | $738M | $662M | $630M | $358M | $391M | · | $357M | $434M | $406M | · | $414M | |
| PP&E (Net) | $71M | $73M | $74M | $75M | $75M | $71M | $70M | · | $67M | $64M | · | $78M | $79M | · | · | · | |
| Accum. Depreciation | · | · | $126M | · | · | · | $139M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $482M | $482M | $484M | $484M | $484M | $477M | $529M | $536M | $530M | $531M | · | $594M | $597M | $597M | · | $573M | |
| Intangibles | $478M | $496M | $516M | $535M | $556M | $569M | $617M | $641M | $659M | $680M | · | $758M | $782M | $804M | · | $835M | |
| Other Non-current Assets | $19M | $19M | $19M | $20M | $20M | $19M | $19M | $19M | $8M | $9M | · | $9M | $9M | $8M | · | $10M | |
| Total Assets | $1.83B | $1.86B | $1.93B | $2.00B | $1.97B | $2.13B | $2.20B | $2.26B | $1.98B | $1.97B | · | $2.06B | $2.16B | $2.17B | · | $2.22B | |
| Accounts Payable | $50M | $44M | $41M | $51M | $57M | $59M | $47M | $63M | $82M | $71M | · | $67M | $88M | $81M | · | $50M | |
| Accrued Liabilities | $78M | $83M | $84M | $96M | $91M | $113M | $118M | $123M | $95M | $89M | · | $92M | $99M | $106M | · | $112M | |
| Current Liabilities | $149M | $148M | $147M | $169M | $171M | $296M | $193M | $212M | $220M | $204M | · | $201M | $226M | $222M | · | $267M | |
| Capital Leases | $34M | $36M | $37M | $36M | $37M | $38M | $49M | $52M | $50M | $51M | · | $35M | $25M | $26M | · | $29M | |
| Deferred Tax | $108M | $115M | $126M | $130M | $113M | $129M | $141M | $128M | $119M | $122M | · | $138M | $133M | $130M | · | $135M | |
| Other Non-current Liabilities | $17M | $20M | $23M | $25M | $28M | $30M | $33M | $37M | $20M | $21M | · | $26M | $27M | $28M | · | $23M | |
| Total Liabilities | $645M | $652M | $664M | $690M | $676M | $817M | $835M | $853M | $585M | $721M | · | $612M | $624M | $618M | · | $596M | |
| Long-term Debt | $349M | $346M | $344M | $344M | $343M | $439M | $437M | $441M | $202M | $350M | $50.6K | $251M | $250M | $245M | · | $245M | |
| Total Debt | $3M | $4M | · | $4M | $4M | $4M | · | $5M | $5M | $6M | · | $10M | $11M | · | · | · | |
| Common Stock | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $7M | · | $8M | $8M | $8M | · | $8M | |
| Paid-in Capital | $3.56B | $3.57B | $3.57B | $3.58B | $3.60B | $3.48B | $3.48B | $3.52B | $3.54B | $3.39B | · | $3.43B | $3.43B | $3.42B | · | $3.42B | |
| Retained Earnings | $-2.35B | $-2.35B | $-2.29B | $-2.26B | $-2.28B | $-2.13B | $-2.07B | $-2.08B | $-2.10B | $-2.09B | · | $-1.95B | $-1.86B | $-1.84B | · | $-1.74B | |
| Treasury Stock | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| AOCI | $-28M | $-27M | $-21M | $-25M | $-25M | $-45M | $-56M | $-40M | $-47M | $-45M | · | $-46M | $-37M | $-38M | · | $-58M | |
| Stockholders' Equity | $1.18B | $1.20B | $1.27B | $1.31B | $1.30B | $1.31B | $1.37B | $1.40B | $1.40B | $1.25B | $1.39B | $1.44B | $1.54B | $1.55B | $1.56B | $1.63B | |
| Liabilities + Equity | $1.83B | $1.86B | $1.93B | $2.00B | $1.97B | $2.13B | $2.20B | $2.26B | $1.98B | $1.97B | · | $2.06B | $2.16B | $2.17B | · | $2.22B | |
| Shares Outstanding | · | · | · | · | · | · | · | 712,283,206 | 727,176,232 | 726,791,854 | · | 781,711,885 | 781,693,135 | 781,306,164 | 781,306,164 | 781,341,231 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $22M | $22M | $23M | $23M | $23M | $24M | $24M | $24M | $26M | $26M | $26M | $26M | $26M | $25M | $28M | |
| Stock-based Comp | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Deferred Tax | $-6M | $-8M | $-10M | $18M | $-16M | $-7M | $7M | $12M | $-2M | $-3M | $-7M | $6M | $2M | $102.0K | $-26M | $-40M | |
| Amort. of Intangibles | $19M | $19M | $19M | $20M | $19M | $20M | $20M | $20M | $20M | $21M | $21M | $22M | $22M | $21M | $22M | $21M | |
| Other Non-cash | · | $18M | · | · | · | $14M | · | · | · | $21M | · | · | · | $-34M | · | · | |
| Operating Cash Flow | $-44M | $-19M | $-26M | $-35M | $-83M | $-35M | $-44M | $-77M | $-26M | $-36M | $-38M | $33M | $-365.0K | $-23M | $-32M | $-32M | |
| CapEx | $3M | $2M | $3M | $3M | $3M | $3M | $5M | $8M | $7M | $4M | $3M | $4M | $6M | $3M | $6M | $8M | |
| Investing Cash Flow | $16M | $-2M | $-2M | $195M | $-3M | $41M | $116M | $248M | $-7M | $-4M | $-1M | $-4M | $-5M | $-8M | $-8M | $-5M | |
| Stock Repurchased | $13M | $5M | $14M | $15M | $18M | $0 | $16M | $24M | $0 | $50M | $0 | $0 | $0 | $0 | · | · | |
| Net Stock Activity | · | $-5M | · | · | · | $0 | · | · | · | $-50M | · | · | · | · | · | · | |
| Financing Cash Flow | $-13M | $-5M | $-18M | $-16M | $-79M | $-4M | $-40M | $206M | $-2M | $21M | $-4M | $2M | $3M | $-13M | $10M | $8M | |
| Net Change in Cash | $-41M | $-27M | $-46M | $143M | $-164M | $4M | $26M | $379M | $-35M | $-20M | $-43M | $31M | $-3M | $-42M | $-28M | $-30M | |
| Taxes Paid | $35.0K | $-3M | $4M | $763.0K | $18M | $2M | $6M | $2M | $513.0K | $1M | $5M | $-2M | $208.0K | $477.0K | $4M | $-176.0K | |
| Free Cash Flow | · | $-21M | · | · | · | $-38M | · | · | · | $-40M | · | · | · | $-26M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-48M | · | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 48.9% | 36.8% | · | 32.9% | 31.5% | 28.4% | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -4.3% | -41.1% | · | 31.7% | -38.2% | -44.8% | · | 8.2% | -33.9% | -41.1% | · | -36.1% | 2.6% | -12.9% | · | -48.9% | |
| Net Margin | -5.1% | -44.2% | · | 14.3% | -94.7% | -45.1% | · | 14.3% | -5.7% | -47.1% | · | -47.3% | -7.4% | -7.7% | · | -47.9% | |
| Pretax Margin | -8.2% | -49.1% | · | 27.3% | -103.6% | -48.9% | · | 27.9% | -5.8% | -47.9% | · | -43.9% | -6.2% | -7.1% | · | -70.3% | |
| EBITDA Margin | 9.4% | -23.2% | · | 46.7% | -23.6% | -29.1% | · | 22.1% | -20.6% | -26.3% | · | -21.4% | 12.6% | -1.8% | · | -33.3% | |
| ROA | -0.44% | -2.8% | · | 1.0% | -7.5% | -3.3% | · | 1.1% | -0.50% | -4.0% | · | -4.0% | -0.87% | -0.82% | · | -3.7% | |
| ROE | -0.68% | -4.4% | · | 1.6% | -11.0% | -5.3% | · | 1.8% | -0.70% | -5.8% | · | -5.5% | -1.2% | -1.1% | · | -5.1% | |
| ROIC | -0.37% | -3.8% | · | 1.9% | -4.2% | -4.7% | · | 0.52% | -4.3% | -5.6% | · | -4.8% | 0.54% | -2.1% | · | -3.7% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 3.6 | · | 3.7 | 3.4 | 2.5 | · | 3.0 | 1.6 | 1.9 | · | 1.8 | 1.9 | 1.8 | · | 1.5 | |
| Quick Ratio | 2.6 | 2.8 | · | 3.0 | 2.1 | 1.8 | · | 2.4 | 0.7 | 0.9 | · | 1.3 | 1.4 | 1.0 | · | 1.1 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | |
| LT Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -9.3 | · | -19.0 | 2.1 | · | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 1.3 | 1.2 | · | 1.6 | 1.7 | 1.7 | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.8 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.6 | 1.2 | 1.5 | · | 1.5 | 1.4 | 1.4 | · | 1.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | · | $1.97 | $1.92 | $1.72 | · | $1.85 | $1.96 | $1.99 | · | $2.08 | |
| Revenue / Share | $0.22 | $0.16 | · | $0.19 | $0.20 | · | · | $0.17 | · | · | · | · | · | $0.32 | · | $0.24 | |
| Cash Flow / Share | · | $-0.03 | · | · | · | · | · | · | · | · | · | · | · | $-0.03 | · | · | |
| Cash / Share | · | · | · | · | · | · | · | $0.56 | $0.06 | $0.10 | · | $0.18 | $0.14 | $0.14 | · | $0.23 | |
| EPS (TTM) | $-0.09 | $-0.27 | · | $-0.25 | $-0.25 | $-0.07 | · | $-0.19 | $-0.33 | · | · | · | $-0.38 | $-0.38 | · | $-0.44 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $588M | $581M | · | $642M | $664M | $689M | · | $711M | $716M | $800M | · | $867M | $868M | $913M | · | $1.22B | |
| Net Income TTM | $-73M | $-213M | · | $-180M | $-177M | $-39M | · | $-134M | $-243M | $-252M | · | $-208M | $-209M | $-291M | · | $-317M | |
| Market Cap | · | · | · | · | · | · | · | $1.06B | $909M | $872M | · | $1.25B | $1.70B | $1.14B | · | $1.48B | |
| Enterprise Value | · | · | · | · | · | · | · | $666M | $874M | $802M | · | $1.12B | $1.60B | · | · | · | |
| P/E | -16.7 | -4.2 | · | -6.2 | -5.3 | -23.7 | · | -7.8 | -3.8 | · | · | · | -5.7 | -3.8 | · | -4.3 | |
| P/S | · | · | · | · | · | · | · | 1.5 | 1.3 | 1.1 | · | 1.4 | 2.0 | 1.2 | · | 1.2 | |
| P/B | · | · | · | · | · | · | · | 0.8 | 0.7 | 0.7 | · | 0.9 | 1.1 | 0.7 | · | 0.9 | |
| P / Tangible Book | · | · | · | · | · | · | · | 4.7 | 4.4 | 20.7 | · | 13.6 | 10.9 | 7.6 | · | 6.7 | |
| P / Cash Flow | · | · | · | · | · | · | · | · | · | -24.5 | · | · | · | -50.4 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | 0.9 | 1.2 | 1.0 | · | 1.3 | 1.8 | · | · | · | |
| Earnings Yield | -6.0% | -23.7% | · | -16.1% | -18.9% | -4.2% | · | -12.8% | -26.4% | · | · | · | -17.5% | -26.0% | · | -23.3% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $607M | $713M | $863M | $1.00B | $1.77B |
| Bruttogewinnmarge % | 33.9% | · | · | · | · |
| Betriebsgewinnmarge % | -19.4% | · | -18.2% | -22.5% | · |
| Nettoergebnis | $-226M | $-53M | $-189M | $-328M | $-30M |
| Verwässerte EPS | $-0.30 | $-0.08 | $-0.25 | $-0.46 | $-0.05 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.3 | · | 0.0 | · | · |
| Liquiditätsgrad | 4.0 | · | 1.5 | 1.8 | · |
| Quick Ratio | 3.1 | · | 1.1 | 1.3 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-191M | · | $-44M | $-120M | · |
Institutionelle Eigentümer (13F) 247 Einreicher · $344.4M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
247
Gehaltener Wert
$344.4M
Neue Positionen
24
Geschlossene Positionen
31
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 24 (-22 vs. Vorquartal) | 31 (+7 vs. Vorquartal) | 76 (+21 vs. Vorquartal) | 50 (-15 vs. Vorquartal) | +1.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Rubric Capital Management LP | $71.686.865 | 47.791.243 | 20,81% | Aktien |
| BlackRock, Inc. | $55.468.342 | 36.978.893 | 16,10% | Aktien |
| VANGUARD GROUP INC | $40.896.813 | 32.457.788 | 11,87% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $22.453.395 | 14.968.930 | 6,52% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $22.402.386 | 14.934.924 | 6,50% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $17.375.151 | 11.581.027 | 5,04% | Aktien |
| STATE STREET CORP | $15.463.605 | 10.309.070 | 4,49% | Aktien |
| GOLDMAN SACHS GROUP INC | $10.553.239 | 7.035.492 | 3,06% | Aktien |
| UBS Group AG | $7.509.427 | 5.006.284 | 2,18% | Aktien |
| Whitefort Capital Management, LP | $6.767.118 | 4.511.412 | 1,96% | Aktien |
| NORTHERN TRUST CORP | $5.634.246 | 3.756.163 | 1,64% | Aktien |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | $5.426.827 | 3.593.925 | 1,58% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $5.395.470 | 3.596.980 | 1,57% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $4.059.353 | 2.706.235 | 1,18% | Aktien |
| AWM Investment Company, Inc. | $3.165.000 | 2.110.000 | 0,92% | Aktien |
| MORGAN STANLEY | $2.962.542 | 1.975.027 | 0,86% | Aktien |
| CITADEL ADVISORS LLC | $2.131.383 | 1.420.922 | 0,62% | Aktien |
| WASHINGTON GROWTH STRATEGIES LLC | $2.034.186 | 1.356.124 | 0,59% | Aktien |
| Bank of New York Mellon Corp | $1.994.961 | 1.329.974 | 0,58% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $1.902.026 | 1.267.741 | 0,55% | Aktien |
| Y.D. More Investments Ltd | $1.876.217 | 1.257.568 | 0,54% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $1.859.101 | 1.239.399 | 0,54% | Aktien |
| OP Asset Management Ltd | $1.739.471 | 1.159.647 | 0,51% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $1.641.167 | 1.094.111 | 0,48% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.442.226 | 961.484 | 0,42% | Aktien |
| Clearstead Advisors, LLC | $1.324.932 | 883.288 | 0,38% | Aktien |
| Nuveen, LLC | $1.294.553 | 863.035 | 0,38% | Aktien |
| BANK OF AMERICA CORP /DE/ | $1.193.573 | 795.716 | 0,35% | Aktien |
| Swiss National Bank | $1.142.183 | 761.455 | 0,33% | Aktien |
| Invesco Ltd. | $1.027.615 | 685.076 | 0,30% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $935.342 | 623.561 | 0,27% | Aktien |
| PFG Investments, LLC | $915.737 | 610.491 | 0,27% | Aktien |
| Kovack Advisors, Inc. | $804.303 | 536.202 | 0,23% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $769.327 | 674.848 | 0,22% | Aktien |
| RHUMBLINE ADVISERS | $748.287 | 498.861 | 0,22% | Aktien |
| VAN ECK ASSOCIATES CORP | $657.968 | 438.645 | 0,19% | Aktien |
| COMMONWEALTH EQUITY SERVICES, LLC | $647.840 | 431.894 | 0,19% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $618.077 | 412.051 | 0,18% | Aktien |
| DEUTSCHE BANK AG\ | $597.905 | 398.603 | 0,17% | Aktien |
| ALGERT GLOBAL LLC | $595.545 | 397.030 | 0,17% | Aktien |
| WELLS FARGO & COMPANY/MN | $531.059 | 354.039 | 0,15% | Aktien |
| Legal & General Group Plc | $520.181 | 346.787 | 0,15% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $504.655 | 442.680 | 0,15% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $441.020 | 294.013 | 0,13% | Aktien |
| ROYAL BANK OF CANADA | $435.000 | 289.812 | 0,13% | Aktien |
| XTX Topco Ltd | $429.260 | 286.173 | 0,12% | Aktien |
| Assenagon Asset Management S.A. | $425.502 | 285.339 | 0,12% | Aktien |
| Creative Planning | $369.098 | 246.065 | 0,11% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $367.232 | 244.821 | 0,11% | Aktien |
| JANE STREET GROUP, LLC | $344.181 | 229.454 | 0,10% | Aktien |
Aktivisten & 5%+-Eigentümer 21 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL, Frost Gamma Investments Trust, Frost Nevada Investments Trust ×3 Einreichungen | 1. Juli 2026 | 34,10% | Änderung | · | SEC |
| HSIAO JANE PH D, Hsu Gamma Investments, LP | 3. April 2025 | 4,50% | Änderung | · | SEC |
| OPKO Health, Inc. ×30 Einreichungen | 20. November 2024 | · | Erste Einreichung | · | SEC |
| Frost Gamma Investments Trust, Frost Nevada Investments Trust, Phillip Frost, M.D. ×6 Einreichungen | 15. November 2024 | · | Erste Einreichung | · | SEC |
| Hsu Gamma Investments, LP, Jane H. Hsiao, Ph.D. ×2 Einreichungen | 24. Januar 2024 | · | Erste Einreichung | · | SEC |
| Gary J. Nabel, M.D., Ph.D., Elizabeth G. Nabel, M.D., Coe M. Magruder, EGN 2021 Trust, GJN 2021 Trust, Nabel Family Investments LLC | 29. Juni 2022 | · | Erste Einreichung | Passive Anlage | SEC |
| Elias A. Zerhouni, M.D., Bruce C. Holbrook, EAZ Zeraz Trust, Zerhouni Irrevocable Trust | 29. Juni 2022 | · | Erste Einreichung | Passive Anlage | SEC |
| Hsu Gamma Investment, L.P., Jane Hsiao, Ph.D. | 20. März 2020 | · | Erste Einreichung | · | SEC |
| The Chiin Hsiung Hsiao Family Trust A, The Chiin Hsiung Hsiao Family Trust B, Hsu Gamma Investment, L.P., Jane Hsiao, Ph.D. | 1. November 2019 | · | Erste Einreichung | Passive Anlage | SEC |
| The Frost Group, LLC, Frost Gamma Investments Trust, Frost Nevada Investments Trust, Phillip Frost, M.D. ×15 Einreichungen | 1. November 2019 | · | Erste Einreichung | Passive Anlage | SEC |
| The Chiin Hsiung Hsiao Family Trust A (2), The Chiin Hsiung Hsiao Family Trust B (2), Hsu Gamma Investment, L.P. (2), Jane Hsiao, Ph.D. (2) | 20. November 2018 | · | Erste Einreichung | · | SEC |
| Jane Hsiao, Ph.D., The Chiin Hsiung Hsiao Family Trust A, The Chiin Hsiung Hsiao Family Trust B, Hsu Gamma Investment, L.P. ×4 Einreichungen | 18. Dezember 2015 | · | Erste Einreichung | Passive Anlage | SEC |
| The Frost Group, LLC (2), Frost Gamma Investments Trust (2), Phillip Frost, M.D. (2) ×4 Einreichungen | 17. Februar 2015 | · | Erste Einreichung | Passive Anlage | SEC |
| OPKO Health, Inc. (2) ×2 Einreichungen | 7. Januar 2014 | · | Erste Einreichung | · | SEC |
| Jane Hsiao, Ph.D. (2), The Chiin Hsiung Hsiao Family Trust A (2), The Chiin Hsiung Hsiao Family Trust B (2), Hsu Gamma Investment, L.P. (2) | 16. September 2013 | · | Erste Einreichung | M&A / Verkauf | SEC |
| Psilos Group Partners II-S, L.P., Psilos Group Investors II-S, L.L.C., Psilos Group Managers, LLC | 10. März 2008 | · | Erste Einreichung | M&A / Verkauf | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 14. Februar 2008 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 14. Februar 2008 | · | Erste Einreichung | Passive Anlage | SEC |
| NEW VALLEY LLC, VECTOR GROUP LTD. ×2 Einreichungen | 12. April 2007 | · | Erste Einreichung | · | SEC |
| eXegenics, Inc. Fed. Id. | 16. Februar 2007 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 22. August 2003 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 35 Insider · 11 Führungskräfte · 23 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Phillip Frost, M.D. | CEO & Chairman | 27. Mai 2025 A | 3.568.951 | 0 | 0 | $0 |
| Adam Logal | Sr. Vice President, CFO | 24. Juli 2026 F | 563.396 | 0 | 0 | $0 |
| Juan F Rodriguez | Sr. Vice President, CFO | 16. Juli 2012 A | · | 0 | 0 | $0 |
| Elias A. Zerhouni | Vice Chairman and President | 27. Mai 2025 A | 589.600 | 0 | 0 | $0 |
| Dale R Pfost | President | 29. März 2007 J | 1.687.261 | 0 | 0 | $0 |
| Steven D Rubin | Executive VP-Administration | 24. Juli 2026 F | 6.571.966 | 0 | 0 | $0 |
| Gary J. Nabel | Chief Innovation Officer | 27. Mai 2025 A | 700.579 | 0 | 0 | $0 |
| HSIAO JANE PH D | Vice Chairman & CTO | 27. Mai 2025 A | 28.499.880 | 0 | 0 | $0 |
| Jon R Cohen | SVP OPKO; Exec Chairman BRLI | 10. Mai 2021 P | 125.000 | 0 | 0 | $0 |
| Naveed K Shams | Chief Medical Officer & Sr. VP of Research & Development | 7. Juli 2008 P | 6.200 | 0 | 0 | $0 |
| Samuel J Reich | Executive VP | 29. März 2007 J | 490.021 | 0 | 0 | $0 |
| Prem A Lachman | Direktor | 18. Juni 2026 A | · | 0 | 0 | $0 |
| Alice Lin-Tsing Yu | Direktor | 18. Juni 2026 A | 100.000 | 0 | 0 | $0 |
| Subbarao V Uppaluri | Direktor | 18. Juni 2026 A | 162.000 | 0 | 0 | $0 |
| John A Paganelli | Direktor | 18. Juni 2026 A | 394.340 | 1 | 0 | $11.400 |
| Richard C Pfenniger JR | Direktor | 18. Juni 2026 A | 325.000 | 0 | 0 | $0 |
| Roger Medel MD | Direktor | 18. Juni 2026 A | · | 0 | 0 | $0 |
| Richard M Krasno | Direktor | 23. April 2025 A | 103.333 | 0 | 0 | $0 |
| Alexis Borisy | Direktor | 22. Juni 2023 A | 312.612 | 0 | 0 | $0 |
| Anthony J Japour | Direktor | 12. März 2020 P | 1.000 | 0 | 0 | $0 |
| Robert A Baron | Direktor | 19. Januar 2017 M | 320.773 | 0 | 0 | $0 |
| Dmitry Kolosov | Direktor | 5. Mai 2016 A | · | 0 | 0 | $0 |
| Pascal J Goldschmidt | Direktor | 9. Juni 2011 A | · | 0 | 0 | $0 |
| Michael Reich | Direktor | 6. Januar 2009 M | 202.858 | 0 | 0 | $0 |
| David A Eichler | Direktor | 19. September 2007 A | · | 0 | 0 | $0 |
| Melvin L Rubin MD | Direktor | 3. Mai 2007 A | · | 0 | 0 | $0 |
| SPENCER DAVID LEE | Direktor | 3. Juli 2006 A | 809.100 | 0 | 0 | $0 |
| Robert S Benou | Direktor | 3. Juli 2006 A | 35.000 | 0 | 0 | $0 |
| Frost Gamma Investments Trust | 10%-Eigentümer | 13. Juli 2007 P | 40.589.183 | 0 | 0 | $0 |
| Frost Group, LLC | 10%-Eigentümer | 27. März 2007 A | · | 0 | 0 | $0 |
| Robert Scott Fishel | · | 24. Juni 2021 A | 60.000 | 0 | 0 | $0 |
| Richard A Lerner | · | 24. Juni 2021 A | 178.881 | 0 | 0 | $0 |
| Thomas E Beier | · | 13. Januar 2017 M | 60.000 | 0 | 0 | $0 |
| John J Huntz JR | · | 27. Mai 2004 A | 35.000 | 0 | 0 | $0 |
| Gordon F Martin | · | 10. November 2003 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 25 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,56% | 81.577 SH | 2. Oktober 2026 | Täglich |
| IHF · iShares Trust | 0,09% | 812.780 SH | 11. September 2026 | Täglich |
| IBB · iShares Trust | 0,04% | 2.900.603 SH | 11. September 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 351.316 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 388.300 SH | 2. Oktober 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 2.317.304 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,02% | 10.285.776 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,02% | 192.494 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 4.912.704 SH | 19. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,01% | 6.907.600 SH | 19. August 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | 0,01% | 1.985.904 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 1.144.903 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 180.345 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 27.415 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,00% | 61.542 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 750.709 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 103.561 SH | 4. September 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 303.828 NS | 31. Juli 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,00% | 2.195.542 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 9.753.393 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 32.355 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 3.804.615 SH | 11. September 2026 | Täglich |
| ISCB · iShares Trust | · | 17.135 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 86.918 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 130.704 SH | 1. September 2026 | Täglich |
OPK Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 10 Analysten
KAUF
Median-Ziel
$3.00
+92,3%
2 20,0%
Starker Kauf
5 50,0%
Kauf
3 30,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
4 Analysten · 2026-10-03Mittelwert-Ziel $4.38 +180,4%
← Unter allen Zielen
Aktueller Preis $1.56
Tief$3.00
Mittelwert$4.38
Hoch$8.50
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| OPK | · | -4.2 | -14.9% | -37.2% | -17.6% | 33.9% |
| AMN | $606M | -6.4 | -8.5% | -3.5% | -15.3% | 28.3% |
| AGL | $7.14B | · | -2.1% | -6.6% | -146.1% | · |
| PNTG | $975M | 33.5 | 36.3% | 3.1% | 8.4% | · |
| OMDA | $922M | -45.1 | 53.2% | -4.9% | -5.8% | 65.7% |
| INNV | $1.61B | -592.5 | 15.9% | -0.26% | -1.1% | 23.0% |
| CSTL | $1.15B | -46.9 | 3.7% | -7.0% | -5.2% | · |
| LMRI | · | · | · | · | · | · |
| FLGT | $816M | -84.7 | 13.8% | -18.8% | -5.4% | 40.6% |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q/A eingereicht Aug 28, 2026